Business Description
Sansure Biotech Inc
ISIN : CNE1000043J1
Share Class Description:
SHSE:688289: Class ACompare
Compare
Traded in other countries / regions
688289.China IPO Date
2020-08-28Description
Sansure Biotech Inc is engaged in production and sales of diagnostic reagents and instruments. The company produces Class I medical devices, Class II medical devices, Class III medical devices, general instruments and meters, medical raw materials, medical laboratory equipment and appliances, and medical accessories.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 11.61 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 0.97 | |||||
Interest Coverage | 12.03 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 7.2 | |||||
Beneish M-Score | -1.55 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -41.6 | |||||
3-Year EBITDA Growth Rate | -45.6 | |||||
3-Year EPS without NRI Growth Rate | -70.5 | |||||
3-Year Book Growth Rate | 15.1 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.29 | |||||
9-Day RSI | 36.22 | |||||
14-Day RSI | 38.04 | |||||
6-1 Month Momentum % | 9.28 | |||||
12-1 Month Momentum % | 16.21 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.48 | |||||
Quick Ratio | 7.94 | |||||
Cash Ratio | 6.86 | |||||
Days Inventory | 438.63 | |||||
Days Sales Outstanding | 245.67 | |||||
Days Payable | 579.42 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.88 | |||||
Dividend Payout Ratio | 1.19 | |||||
3-Year Dividend Growth Rate | 11.3 | |||||
Forward Dividend Yield % | 4.34 | |||||
5-Year Yield-on-Cost % | 4.83 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 3.91 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75.31 | |||||
Operating Margin % | 7.51 | |||||
Net Margin % | 31.98 | |||||
FCF Margin % | -24.88 | |||||
ROE % | 5.24 | |||||
ROA % | 4.53 | |||||
ROIC % | 2.81 | |||||
ROC (Joel Greenblatt) % | 33.35 | |||||
ROCE % | 5.78 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 27.98 | |||||
PE Ratio without NRI | 31.36 | |||||
Price-to-Owner-Earnings | 82.09 | |||||
PS Ratio | 8.9 | |||||
PB Ratio | 1.49 | |||||
Price-to-Tangible-Book | 1.56 | |||||
Price-to-Operating-Cash-Flow | 288.59 | |||||
EV-to-EBIT | 14.38 | |||||
EV-to-EBITDA | 14.38 | |||||
EV-to-Revenue | 5.26 | |||||
EV-to-FCF | -21.13 | |||||
Price-to-Graham-Number | 1.47 | |||||
Price-to-Net-Current-Asset-Value | 2.33 | |||||
Price-to-Net-Cash | 3.09 | |||||
Earnings Yield (Greenblatt) % | 6.95 | |||||
FCF Yield % | -2.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sansure Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,202.893 | ||
EPS (TTM) (Â¥) | 0.66 | ||
Beta | 0.83 | ||
Volatility % | 32.59 | ||
14-Day RSI | 38.04 | ||
14-Day ATR (Â¥) | 0.50257 | ||
20-Day SMA (Â¥) | 19.2845 | ||
12-1 Month Momentum % | 16.21 | ||
52-Week Range (Â¥) | 14.72 - 22 | ||
Shares Outstanding (Mil) | 588.46 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sansure Biotech Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sansure Biotech Inc Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Sansure Biotech Inc Frequently Asked Questions
What is Sansure Biotech Inc(SHSE:688289)'s stock price today?
The current price of SHSE:688289 is ¥18.53. The 52 week high of SHSE:688289 is ¥22.00 and 52 week low is ¥14.72.
When is next earnings date of Sansure Biotech Inc(SHSE:688289)?
The next earnings date of Sansure Biotech Inc(SHSE:688289) is .
Does Sansure Biotech Inc(SHSE:688289) pay dividends? If so, how much?
The Dividend Yield %  of Sansure Biotech Inc(SHSE:688289) is 4.88% (As of Today), Highest Dividend Payout Ratio of Sansure Biotech Inc(SHSE:688289) was 5.83. The lowest was 0.11. And the median was 0.3. The  Forward Dividend Yield % of Sansure Biotech Inc(SHSE:688289) is 4.34%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |